IRADIMED CORPORATION Increase (Decrease) in Accounts Receivable
IRADIMED CORPORATION (IRMD) reported Increase (Decrease) in Accounts Receivable of -$492.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-31
- IRADIMED CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$280.00K.
- IRADIMED CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$212.00K, a 109.93% decline year-over-year.
- IRADIMED CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$191.43K, a 201.35% decline year-over-year.
- IRADIMED CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $2.89M.
- IRADIMED CORPORATION increase (decrease) in accounts receivable for fiscal 2025 was $3.03M.
- IRADIMED CORPORATION increase (decrease) in accounts receivable for fiscal 2024 was -$1.76M.
- IRADIMED CORPORATION increase (decrease) in accounts receivable for fiscal 2023 was -$841.91K, a 110.22% decline from fiscal 2022.
- IRADIMED CORPORATION increase (decrease) in accounts receivable for fiscal 2022 was $8.24M, a 1331.81% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$280.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$492.00K 10-Q · filed 2026-07-31 | -$683.43K derived: sum of 3 quarters · filed 2026-07-31 | $2.20M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | -$212.00K 10-Q · filed 2026-05-01 | -$403.43K derived: sum of 2 quarters · filed 2026-05-01 | $2.48M derived: sum of 3 quarters · filed 2026-05-01 | $680.00K derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | -$191.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.69M derived: sum of 2 quarters · filed 2026-03-06 | $892.00K derived: sum of 3 quarters · filed 2026-07-31 | $3.03M 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.08M derived: sum of 2 quarters · filed 2026-07-31 | $3.22M 10-Q · filed 2025-11-03 | $3.41M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $333.00K 10-Q · filed 2026-07-31 | $332.51K 10-Q · filed 2025-08-01 | $521.88K derived: sum of 3 quarters · filed 2026-07-31 | -$1.18M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-03-31 | $2.13M 10-Q · filed 2026-05-01 | $2.13M 10-Q · filed 2025-05-05 | $2.32M derived: sum of 2 quarters · filed 2026-05-01 | $625.40K derived: sum of 3 quarters · filed 2026-05-01 | -$391.32K derived: sum of 4 quarters · filed 2026-05-01 | |||
| 2024-12-31 | $188.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$1.51M derived: sum of 2 quarters · filed 2026-03-06 | -$2.53M derived: sum of 3 quarters · filed 2026-03-06 | -$1.76M 10-K · filed 2026-03-06 | -$1.76M 10-K · filed 2025-03-06 | |||
| 2024-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$2.72M derived: sum of 2 quarters · filed 2025-11-03 | -$1.95M 10-Q · filed 2025-11-03 | -$2.45M derived: sum of 4 quarters · filed 2025-11-03 | ||||
| 2024-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$252.40K 10-Q · filed 2025-08-01 | -$751.26K derived: sum of 3 quarters · filed 2025-09-03 | $927.09K derived: sum of 4 quarters · filed 2025-09-03 | ||||
| 2024-03-31 | $764.32K 10-Q · filed 2025-05-05 | $265.46K derived: sum of 2 quarters · filed 2025-09-03 | $1.94M derived: sum of 3 quarters · filed 2025-09-03 | $1.48M derived: sum of 4 quarters · filed 2025-09-03 | ||||
| 2023-12-31 | -$498.86K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03 | $1.18M derived: sum of 2 quarters · filed 2025-09-03 | $718.61K derived: sum of 3 quarters · filed 2025-09-03 | -$841.91K 10-K/A · filed 2025-09-03 | ||||
| 2023-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.22M derived: sum of 2 quarters · filed 2024-10-31 | -$343.05K 10-Q · filed 2024-10-31 | $2.33M derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | -$460.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$2.02M 10-Q · filed 2024-08-01 | $648.50K derived: sum of 3 quarters · filed 2024-08-01 | $2.92M derived: sum of 4 quarters · filed 2024-08-01 | ||||
| 2023-03-31 | -$1.56M 10-Q · filed 2024-05-02 | $1.11M derived: sum of 2 quarters · filed 2024-05-02 | $3.38M derived: sum of 3 quarters · filed 2024-05-02 | $5.30M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $4.95M derived: sum of 2 quarters · filed 2024-03-01 | $6.86M derived: sum of 3 quarters · filed 2024-03-01 | $8.24M 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $4.19M derived: sum of 2 quarters · filed 2023-11-03 | $5.57M 10-Q · filed 2023-11-03 | $6.47M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.30M 10-Q · filed 2023-08-03 | $4.19M derived: sum of 3 quarters · filed 2023-08-03 | $4.56M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $1.38M 10-Q · filed 2023-05-04 | $2.28M derived: sum of 2 quarters · filed 2023-05-04 | $2.65M derived: sum of 3 quarters · filed 2023-05-04 | $1.97M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $897.39K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.27M derived: sum of 2 quarters · filed 2023-03-02 | $584.58K derived: sum of 3 quarters · filed 2023-03-02 | $575.54K 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $369.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$312.82K derived: sum of 2 quarters · filed 2022-11-03 | -$321.85K 10-Q · filed 2022-11-03 | -$13.15K derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$682.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$691.11K 10-Q · filed 2022-08-05 | -$382.41K derived: sum of 3 quarters · filed 2022-08-05 | -$633.92K derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | -$9.03K 10-Q · filed 2022-05-06 | $299.67K derived: sum of 2 quarters · filed 2022-05-06 | $48.16K derived: sum of 3 quarters · filed 2022-05-06 | -$1.29M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $308.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $57.19K derived: sum of 2 quarters · filed 2022-03-04 | -$1.29M derived: sum of 3 quarters · filed 2022-03-04 | -$2.69M 10-K · filed 2022-03-04 | ||||
| 2020-09-30 | -$251.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$1.59M derived: sum of 2 quarters · filed 2021-11-05 | -$3.00M 10-Q · filed 2021-11-05 | -$2.63M derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2020-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$2.75M 10-Q · filed 2021-08-06 | -$2.38M derived: sum of 3 quarters · filed 2022-03-04 | -$1.32M derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2020-03-31 | -$1.40M 10-Q · filed 2021-05-07 | -$1.03M derived: sum of 2 quarters · filed 2022-03-04 | $27.42K derived: sum of 3 quarters · filed 2022-03-04 | $569.94K derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2019-12-31 | $372.13K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $1.43M derived: sum of 2 quarters · filed 2022-03-04 | $1.97M derived: sum of 3 quarters · filed 2022-03-04 | $3.11M 10-K · filed 2022-03-04 | ||||
| 2019-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.60M derived: sum of 2 quarters · filed 2020-11-06 | $2.74M 10-Q · filed 2020-11-06 | $1.72M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-06-30 | $542.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.68M 10-Q · filed 2020-08-06 | $662.95K derived: sum of 3 quarters · filed 2021-03-05 | $1.91M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-03-31 | $1.14M 10-Q · filed 2020-05-07 | $120.43K derived: sum of 2 quarters · filed 2021-03-05 | $1.37M derived: sum of 3 quarters · filed 2021-03-05 | $2.08M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2018-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $232.00K derived: sum of 2 quarters · filed 2021-03-05 | $937.04K derived: sum of 3 quarters · filed 2021-03-05 | $446.90K 10-K · filed 2021-03-05 | ||||
| 2018-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.96M derived: sum of 2 quarters · filed 2019-11-07 | $1.47M 10-Q · filed 2019-11-07 | $1.74M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-06-30 | $705.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $214.90K 10-Q · filed 2019-08-07 | $487.87K derived: sum of 3 quarters · filed 2020-03-06 | $205.82K derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-03-31 | -$490.15K 10-Q · filed 2019-05-08 | -$217.18K derived: sum of 2 quarters · filed 2020-03-06 | -$499.22K derived: sum of 3 quarters · filed 2020-03-06 | -$241.44K derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2017-12-31 | $272.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | -$9.07K derived: sum of 2 quarters · filed 2020-03-06 | $248.71K derived: sum of 3 quarters · filed 2020-03-06 | $201.59K 10-K · filed 2020-03-06 | ||||
| 2017-09-30 | -$282.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$24.27K derived: sum of 2 quarters · filed 2018-11-07 | -$71.38K 10-Q · filed 2018-11-07 | -$795.41K derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-06-30 | $257.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $210.66K 10-Q · filed 2018-08-08 | -$513.37K derived: sum of 3 quarters · filed 2019-03-07 | -$1.82M derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2017-03-31 | -$47.12K 10-Q · filed 2018-05-08 | -$771.14K derived: sum of 2 quarters · filed 2019-03-07 | -$2.08M derived: sum of 3 quarters · filed 2019-03-07 | -$919.40K derived: sum of 4 quarters · filed 2019-03-07 | ||||
| 2016-12-31 | -$724.03K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$2.03M derived: sum of 2 quarters · filed 2019-03-07 | -$872.28K derived: sum of 3 quarters · filed 2019-03-07 | -$75.30K 10-K · filed 2019-03-07 | ||||
| 2016-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$148.26K derived: sum of 2 quarters · filed 2017-11-06 | $648.73K 10-Q · filed 2017-11-06 | $1.07M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $1.96M 10-Q · filed 2017-08-04 | $2.38M derived: sum of 3 quarters · filed 2018-03-08 | $1.51M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | $796.99K 10-Q · filed 2017-05-05 | $1.22M derived: sum of 2 quarters · filed 2018-03-08 | $344.82K derived: sum of 3 quarters · filed 2018-03-08 | $1.10M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2015-12-31 | $423.24K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$452.16K derived: sum of 2 quarters · filed 2018-03-08 | $306.13K derived: sum of 3 quarters · filed 2018-03-08 | $1.91M 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | -$875.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$117.11K derived: sum of 2 quarters · filed 2016-11-04 | $1.48M 10-Q · filed 2016-11-04 | $2.12M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | $758.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.36M 10-Q · filed 2016-08-05 | $3.00M derived: sum of 3 quarters · filed 2017-03-10 | $1.93M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | $1.60M 10-Q · filed 2016-05-06 | $2.24M derived: sum of 2 quarters · filed 2017-03-10 | $1.18M derived: sum of 3 quarters · filed 2017-03-10 | $1.30M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | $639.89K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$425.21K derived: sum of 2 quarters · filed 2017-03-10 | -$305.28K derived: sum of 3 quarters · filed 2017-03-10 | -$130.72K 10-K · filed 2017-03-10 | -$21.87K 10-K · filed 2015-03-23 | |||
| 2014-09-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$945.17K derived: sum of 2 quarters · filed 2015-11-10 | -$770.61K 10-Q · filed 2015-11-10 | -$807.98K 10-Q · filed 2014-11-13 | -$503.94K derived: sum of 4 quarters · filed 2015-11-10 | |||
| 2014-06-30 | $119.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $294.49K 10-Q · filed 2015-08-11 | $294.04K 10-Q · filed 2014-08-14 | $561.16K derived: sum of 3 quarters · filed 2015-08-11 | $593.24K derived: sum of 4 quarters · filed 2015-08-11 | |||
| 2014-03-31 | $174.56K 10-Q · filed 2015-05-11 | $441.24K derived: sum of 2 quarters · filed 2015-05-11 | $473.32K derived: sum of 3 quarters · filed 2015-05-11 | |||||
| 2013-12-31 | $266.68K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $298.75K derived: sum of 2 quarters · filed 2015-03-23 | $396.59K 10-K · filed 2015-03-23 | |||||
| 2013-09-30 | $32.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $129.91K 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | $97.83K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |